Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence of Pathogenic or Likely Pathogenic Germline Variants in Cancer Predisposition Genes Among Patients With Lung Adenocarcinoma

NCT06181812 is registered in ClinicalTrials.gov with Oscar Gerardo Arrieta Rodríguez as lead sponsor.

NCT NCT06181812
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06181812 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence of Pathogenic or Likely Pathogenic Germline Variants in Cancer Predisposition Genes Among Patients With Lung Adenocarcinoma
Lead sponsor
Oscar Gerardo Arrieta Rodríguez
Phase
Observational
Overall status
Recruiting
Start date
December 15, 2022
Completion date
December 15, 2027
Enrollment
332 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung adenocarcinoma